IP Library Granted Patent US 8,394,581
Granted Patent B2
US 8,394,581 · App. 12/670,592 · Granted Mar 12, 2013

Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test

Inventors: Tsutomu Hohdatsu (Aomori, JP); Kenji Motokawa (Saitama, JP); Hajime Kusuhara (Saitama, JP)
Assignee: The Kitasato Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,581
App. No.
12/670,592
Granted
Mar 12, 2013
Kind
B2
Abstract

Since FIV-vaccinated cats produce antibodies against FIV, distinguishing them from FIV-infected cats is difficult by serological diagnostic methods using FIV and FIV-derived substances. The present invention enables tests for determining the presence or absence of a FIV vaccination history in a cat by detecting antibodies that are produced as a result of vaccination of a cat with an FIV vaccine, but not as a result of FIV infection. Using the methods of the present invention, whether an anti-FIV antibody-positive cat is infected with FIV or has been vaccinated can be conveniently distinguished.

Claims (10)

1. A method for testing the presence or absence of a feline immunodeficiency virus (FIV) vaccination history in a cat, the method comprising detecting an antibody against a non-FIV-derived cellular component in a test sample from the cat using an antigen-antibody reaction, wherein the antibody is produced as a result of vaccination with an FIV vaccine but not as a result of FIV infection and the cat is determined to have an FIV vaccination history when the antibody is detected.

2. The test method of claim 1 , wherein the non-FIV-derived cellular component is a cell membrane, cytoplasm, nucleus, or cytoskeleton of an FIV-infected cell utilized to produce the FIV vaccine.

3. The test method of claim 1 , wherein the non-FIV-derived cellular component is a cellular component of a feline-derived cell.

4. The test method of claim 1 , wherein the non-FIV-derived cellular component is a cellular component of a cell derived from a non-feline animal.

5. The test method of claim 1 , wherein serum, plasma, or whole blood derived from the cat is used as the test sample.

6. The test method of claim 2 , wherein the non-FIV-derived cellular component is a cellular component of a feline-derived cell.

7. The test method of claim 2 , wherein the non-FIV-derived cellular component is a cellular component of a cell derived from a non-feline animal.

8. The test method of claim 2 , wherein serum, plasma, or whole blood derived from the cat is used as the test sample.

9. The test method of claim 3 , wherein serum, plasma, or whole blood derived from the cat is used as the test sample.

10. The test method of claim 4 , wherein serum, plasma, or whole blood derived from the cat is used as the test sample.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2014
From: KITASATO DAIICHI SANKYO VACCINE CO., LTD.
To: THE KITASATO INSTITUTE
Reel/Frame 033622/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2012
From: THE KITASATO INSTITUTE
To: KITASATO DAIICHI SANKYO VACCINE CO., LTD.
Reel/Frame 028036/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2010
From: HOHDATSU, TSUTOMU; MOTOKAWA, KENJI; KUSUHARA, HAJIME
To: THE KITASATO INSTITUTE
Reel/Frame 024396/0027 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2010
From: HOHDATSU, TSUTOMU; MOTOKAWA, KENJI; KUSUHARA, HAJIME
To: THE KITASATO INSTITUTE
Reel/Frame 024385/0978 →
Priority Claims (1)
JP 2007-192975 · Jul 25, 2007 · national
Continuity (1)
Related Publication 20100267047A1 · Oct 21, 2010